Want to learn more? Sign up to receive educational material about EarlyCDT-Lung! Free Lung Cancer Risk Assessment
text

ORDER THE LUNG CANCER EARLY DETECTION TEST IF…

You or a loved one are 40-75 with one or more of these risk factors:

a. Long-term smoker or former smoker
b. Secondhand smoke exposure for extended periods of time
c. Family history
d. Prolonged environmental exposure to radon, asbestos, coal products, diesel fumes and/or radioactive substances
e. Prolonged exposure to chemicals such as arsenic, vinyl chloride and/or other carcinogens
f. Diagnosed with tuberculosis, silicosis and/or berylliosis with or without scarring of the lung

THIS TEST IS NOT INTENDED FOR PATIENTS WHO HAVE PREVIOUSLY HAD CANCER.

a.

DON’T WAIT FOR SYMPTOMS!

Remember Cancer Is Progressive

Lung cancer claims more lives each year than breast, colon, liver, kidney and melanoma cancers combined, due in part to inadequate early detection.(1) Generally speaking, lung cancer symptoms do not appear until later stages of the disease when 5-year survival can be as low as 4%.(2)

a.

HOW TO ORDER THE TEST

Call 1-888-583-9030 to have a free EarlyCDT®-Lung test kit

Click here or call 1-888-583-9030 to have a free EarlyCDT-Lung test kit mailed to your home. You will take the kit to your physician to have your blood drawn. Your test results will be sent back to your physician within 10 days of your appointment.

a.

WHAT THE RESULTS MEAN

What if a test is positive or negative?

A High Positive or Positive test result means autoantibodies (how a body responds to cancer) have been detected at an elevated level. Your doctor may recommend additional testing such as imaging to determine if you have lung cancer.
If your result is Low Negative or Negative , your doctor will probably recommend that you continue your regular schedule of testing & examination. A negative test means that none of the antibodies were found above the cutoff level. However, you are still at risk for lung cancer due to your risk factors.

(1) American Cancer Society. The Lung Cancer Treatment Guidelines for Patients. 2008; version IV:7
(2) National Cancer Institute: Seer Cancer Statistics Review, 1973-2006